318 related articles for article (PubMed ID: 29672914)
1. Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
Khoury P; Akuthota P; Ackerman SJ; Arron JR; Bochner BS; Collins MH; Kahn JE; Fulkerson PC; Gleich GJ; Gopal-Srivastava R; Jacobsen EA; Leiferman KM; Francesca LS; Mathur SK; Minnicozzi M; Prussin C; Rothenberg ME; Roufosse F; Sable K; Simon D; Simon HU; Spencer LA; Steinfeld J; Wardlaw AJ; Wechsler ME; Weller PF; Klion AD
J Leukoc Biol; 2018 Jul; 104(1):69-83. PubMed ID: 29672914
[TBL] [Abstract][Full Text] [Related]
2. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD).
Bochner BS; Book W; Busse WW; Butterfield J; Furuta GT; Gleich GJ; Klion AD; Lee JJ; Leiferman KM; Minnicozzi M; Moqbel R; Rothenberg ME; Schwartz LB; Simon HU; Wechsler ME; Weller PF
J Allergy Clin Immunol; 2012 Sep; 130(3):587-96. PubMed ID: 22935587
[TBL] [Abstract][Full Text] [Related]
3. Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
Khoury P; Roufosse F; Kuang FL; Ackerman SJ; Akuthota P; Bochner BS; Johansson MW; Mathur SK; Ogbogu PU; Spencer LA; Wechsler ME; Zimmermann N; Klion AD;
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38457125
[TBL] [Abstract][Full Text] [Related]
4. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
Van Hulst G; Bureau F; Desmet CJ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576313
[TBL] [Abstract][Full Text] [Related]
6. The Eosinophil in Health and Disease: from Bench to Bedside and Back.
Liao W; Long H; Chang CC; Lu Q
Clin Rev Allergy Immunol; 2016 Apr; 50(2):125-39. PubMed ID: 26410377
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
[TBL] [Abstract][Full Text] [Related]
8. Improving Care in Eosinophil-Associated Diseases: A Charter.
Jackson DJ; Akuthota P; Andradas R; Bredenoord AJ; Cordell A; Gray S; Kullman J; Mathur SK; Pavord I; Roufosse F; Rubio C; Rusek IC; Simon D; Strobel MJ; Winders T
Adv Ther; 2022 Jun; 39(6):2323-2341. PubMed ID: 35489014
[TBL] [Abstract][Full Text] [Related]
9. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of eosinophilia and eosinophil activation in the development of non-allergic bronchial hyperresponsiveness in guinea pigs injected with Sephadex beads.
Maghni K; Simard MJ; Arseneault D; Sirois P
Inflammation; 1996 Oct; 20(5):523-35. PubMed ID: 8894716
[TBL] [Abstract][Full Text] [Related]
11. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.
Kliewer KL; Murray-Petzold C; Collins MH; Abonia JP; Bolton SM; DiTommaso LA; Martin LJ; Zhang X; Mukkada VA; Putnam PE; Kellner ES; Devonshire AL; Schwartz JT; Kunnathur VA; Rosenberg CE; Lyles JL; Shoda T; Klion AD; Rothenberg ME
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):803-815. PubMed ID: 37336228
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases.
Desreumaux P; Janin A; Dubucquoi S; Copin MC; Torpier G; Capron A; Capron M; Prin L
Blood; 1993 Sep; 82(5):1553-60. PubMed ID: 8364205
[TBL] [Abstract][Full Text] [Related]
13. The Role of Eosinophils in Immunotherapy.
Cafone J; Ruffner MA; Spergel JM
Curr Allergy Asthma Rep; 2020 Jan; 20(1):1. PubMed ID: 31912246
[TBL] [Abstract][Full Text] [Related]
14. Approach to Patients with Eosinophilia.
Kuang FL
Med Clin North Am; 2020 Jan; 104(1):1-14. PubMed ID: 31757229
[TBL] [Abstract][Full Text] [Related]
15. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.
Fauci AS; Harley JB; Roberts WC; Ferrans VJ; Gralnick HR; Bjornson BH
Ann Intern Med; 1982 Jul; 97(1):78-92. PubMed ID: 7046556
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson DJ; Akuthota P; Roufosse F
Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35082127
[TBL] [Abstract][Full Text] [Related]
17. Role of peripheral and tissue eosinophils and eosinophil cationic protein in pediatric inflammatory bowel disease.
Kim YI; Yang HR
J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):653-661. PubMed ID: 38504407
[TBL] [Abstract][Full Text] [Related]
18. Association of Peripheral Blood and Cutaneous Eosinophils With Bullous Pemphigoid Disease Severity and Treatment Outcomes.
Garrido PM; Aguado-Lobo M; Espinosa-Lara P; Soares-Almeida L; Filipe P
Actas Dermosifiliogr; 2022 Oct; 113(9):881-887. PubMed ID: 35659610
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
[TBL] [Abstract][Full Text] [Related]
20. Repeated sensitization of mice with microfilariae of Litomosoides sigmodontis induces pulmonary eosinophilia in an IL-33-dependent manner.
Lenz B; Ehrens A; Ajendra J; Risch F; Gal J; Neumann AL; Reichwald JJ; Strutz W; McSorley HJ; Martin C; Hoerauf A; Hübner MP
PLoS Pathog; 2024 Mar; 20(3):e1012071. PubMed ID: 38457461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
